Log in to save to my catalogue

AIBP: A New Safeguard against Glaucomatous Neuroinflammation

AIBP: A New Safeguard against Glaucomatous Neuroinflammation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3efc19e6cb4f475d98db2e4d9ea7e77b

AIBP: A New Safeguard against Glaucomatous Neuroinflammation

About this item

Full title

AIBP: A New Safeguard against Glaucomatous Neuroinflammation

Publisher

Switzerland: MDPI AG

Journal title

Cells (Basel, Switzerland), 2024-01, Vol.13 (2), p.198

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Glaucoma is a group of ocular diseases that cause irreversible blindness. It is characterized by multifactorial degeneration of the optic nerve axons and retinal ganglion cells (RGCs), resulting in the loss of vision. Major components of glaucoma pathogenesis include glia-driven neuroinflammation and impairment of mitochondrial dynamics and bioener...

Alternative Titles

Full title

AIBP: A New Safeguard against Glaucomatous Neuroinflammation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3efc19e6cb4f475d98db2e4d9ea7e77b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3efc19e6cb4f475d98db2e4d9ea7e77b

Other Identifiers

ISSN

2073-4409

E-ISSN

2073-4409

DOI

10.3390/cells13020198

How to access this item